MEDIFAST INC (MED)vsRollins Inc (ROL)
MED
MEDIFAST INC
$12.23
-1.05%
CONSUMER CYCLICAL · Cap: $134.54M
ROL
Rollins Inc
$46.51
-0.58%
CONSUMER CYCLICAL · Cap: $22.72B
Smart Verdict
WallStSmart Research — data-driven comparison
Rollins Inc generates 1011% more annual revenue ($3.84B vs $346.10M). ROL leads profitability with a 13.8% profit margin vs -5.8%. MED appears more attractively valued with a PEG of 0.97. ROL earns a higher WallStSmart Score of 52/100 (C-).
MED
Hold45
out of 100
Grade: D
ROL
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for MED.
Margin of Safety
+30.2%
Fair Value
$67.65
Current Price
$46.51
$21.14 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Growing faster than its price suggests
Every $100 of equity generates 38 in profit
Areas to Watch
Smaller company, higher risk/reward
Weak financial health signals
ROE of -10.1% — below average capital efficiency
Revenue declined 34.3%
Trading at 16.3x book value
1.3% earnings growth
Weak financial health signals
Expensive relative to growth rate
Comparative Analysis Report
WallStSmart ResearchBull Case : MED
The strongest argument for MED centers on Price/Book, Debt/Equity, Altman Z-Score. PEG of 0.97 suggests the stock is reasonably priced for its growth.
Bull Case : ROL
The strongest argument for ROL centers on Return on Equity. Revenue growth of 10.2% demonstrates continued momentum.
Bear Case : MED
The primary concerns for MED are Market Cap, Piotroski F-Score, Return on Equity.
Bear Case : ROL
The primary concerns for ROL are Price/Book, EPS Growth, Piotroski F-Score. A P/E of 43.3x leaves little room for execution misses.
Key Dynamics to Monitor
MED profiles as a turnaround stock while ROL is a value play — different risk/reward profiles.
ROL carries more volatility with a beta of 0.73 — expect wider price swings.
ROL is growing revenue faster at 10.2% — sustainability is the question.
ROL generates stronger free cash flow (111M), providing more financial flexibility.
Bottom Line
ROL scores higher overall (52/100 vs 45/100) and 10.2% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
MEDIFAST INC
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Medifast, Inc. manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutrition products in the United States and Asia-Pacific. The company is headquartered in Baltimore, Maryland.
Visit Website →Rollins Inc
CONSUMER CYCLICAL · PERSONAL SERVICES · USA
Rollins, Inc. is a North American consumer and commercial services company.
Visit Website →Compare with Other PERSONAL SERVICES Stocks
Want to dig deeper into these stocks?